Mario S Clerici

Title: The Innovative Contributions of Mario S. Clerici

Introduction

Mario S. Clerici is a notable inventor based in Bethesda, MD, contributing significantly to the field of immunology. With a total of four patents to his name, his work primarily focuses on advancing our understanding of immune dysfunction, particularly in the context of HIV-1 infection.

Latest Patents

One of Clerici's latest patents details in vitro methods for assessing the susceptibility of HIV-1-infected individuals to programmed cell death. This innovation highlights calpain as a critical component of the biochemical pathway involved in this process. Importantly, calpain inhibitors have been identified as effective agents that can prevent the progression to cell death and restore immune function. His research demonstrates how T lymphocytes from HIV-infected persons undergo receptor-triggered programmed cell death, suggesting a potential therapeutic avenue through calpain inhibition.

Another significant patent by Clerici is related to methods for diagnosing cell populations or individuals susceptible to programmed cell death, as well as monitoring the effectiveness of treatments. This invention offers a sensitive and accurate tissue culture system and kit to detect subtle changes in immune function, which are crucial for differentiating various stages of immune dysfunction. Additionally, it can predict organ graft rejection by assessing IL-2 production by T helper cells in response to various antigens.

Career Highlights

Mario S. Clerici's career as an inventor underscores his dedication to advancing medical sciences through innovative research. His affiliation with the United States of America, as represented by the Department of Health, reflects his commitment to public health and scientific excellence. His innovative approaches in immunology are paving the way for new diagnostic methods and therapeutic strategies for immunological disorders.

Collaborations

Throughout his career, Clerici has collaborated with respected colleagues, including Gene M. Shearer and Charles S. Via. These partnerships amplify the impact of his inventions, showcasing the synergy of collective expertise in pursuing groundbreaking research in immunology.

Conclusion

Mario S. Clerici's contributions as an inventor continue to shape our understanding of immune response mechanisms, especially in the context of HIV-1 infection. His patents not only advance scientific knowledge but also hold promise for developing new diagnostic tools and therapeutic options. As research evolves, Clerici's work exemplifies the critical role of innovation in enhancing public health.